THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. License Agreements
15 Contracts & Agreements
- Exclusive Patent License Agreement between Therapeutic Solutions International, Inc. and Res Nova Bio, Inc (Filed With SEC on July 27, 2023)
- Exclusive Patent License Agreement between Therapeutic Solutions International, Inc. and CTE Biologics, Inc (Filed With SEC on July 7, 2023)
- Exclusive Patent License Agreement between Therapeutic Solutions International, Inc. and Res Nova Bio, Inc (Filed With SEC on February 21, 2023)
- Exclusive Patent License Agreement between Therapeutic Solutions International, Inc. and Veltmeyer Institute for Advanced Biologics, LLC (Filed With SEC on February 21, 2023)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on June 12, 2017)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on June 1, 2017)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on May 18, 2017)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on May 10, 2017)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on April 18, 2017)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on February 8, 2016)
- TERM SHEET For an exclusive license Agreement (the Agreement) (Filed With SEC on January 25, 2016)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on December 8, 2015)
- EXCLUSIVE PATENT LICENSE AGREEMENT (Filed With SEC on November 18, 2015)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on October 31, 2012)
- LICENSE AGREEMENT (Filed With SEC on August 30, 2012)
